Breaking News
Sort by:
Top Post
10 Million Doses of mRNA-based COVID-19 Vaccine to be supplied to Taiwan Region
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced that Fosun Industrial Co., Limited (“Fosun Industrial”), […]
Arab Participation in Global Genomic Study Could Lead to New Therapies for COVID-19 Patients
In March 2020, thousands of scientists around the world united to answer a pressing and […]
PHE to Provide Genomic Sequencing Support to Partners Across the World
PHE Platform NVAP was announced in January by the Department of Health and Social Care […]
Exscientia Accelerates COVID-19 Drug Discovery Using AI
Exscientia has received a grant from the Bill & Melinda Gates Foundation and Gates Philanthropy […]
Swedish Company Announces New Product VirusShield, A Self-Adhesive Antimicrobial Protection Film That Kills Germs
Everyone needs to play their role in the struggle to end the global pandemic and […]
UK Exceeds 600,000 COVID-19 Tests Genomically Sequenced
The UK has today (Friday 2 July) surpassed another important milestone in the fight against […]
WHO/Europe Launches New Monitoring Tool, Tracking Rates of COVID-19 in UEFA Euro 2020 Host Cities
With the UEFA European Football Championships being played in cities across the WHO European Region, […]
Intranasal COVID-19 Vaccine Demonstrates Single-dose Efficacy in Preclinical Studies, in Parallel with Achievement of Phase 1 Clinical Milestone
Codagenix Inc., a clinical-stage synthetic biology company pioneering a novel platform for vaccines and oncolytic […]
90% of UK’s Leading Health Providers Accelerate Digital Transformation Plans in Response to Covid-19
The UK health sector is fast accelerating its digital transformation plans in response to the […]
COVID-19 Welcomes a New Era in Vaccinology. mRNA Based Vaccines to Reach US$127.3 Billion by the Year 2027
A new market study published by Global Industry Analysts Inc., (GIA) the premier market research […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more